Prevalence of Lp(a) in a real-world Portuguese cohort: implications for cardiovascular risk assessment.

Of note, patients under lipid-lowering therapies were more frequently in higher risk categories (45.2% and 43.5%, respectively), and those with chronic renal disease also exhibited an increasing trend in higher-risk categories, with proportions of 0.6%, 3.8%, and 12.5%, respectively (Table S2).

also in 63,971 other papers